Gene: EPB41L2
Official Full Name: erythrocyte membrane protein band 4.1 like 2provided by HGNC
Gene Summary: Predicted to enable PH domain binding activity; cytoskeletal protein binding activity; and structural molecule activity. Involved in positive regulation of protein localization to cell cortex. Located in several cellular components, including cell cortex; cell junction; and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38028 | EPB41L2 Knockout cell line (HeLa) | Human | EPB41L2 | 1:3~1:6 | Negative | Online Inquiry |
KO38029 | EPB41L2 Knockout cell line (HCT 116) | Human | EPB41L2 | 1:2~1:4 | Negative | Online Inquiry |
KO38030 | EPB41L2 Knockout cell line (HEK293) | Human | EPB41L2 | 1:3~1:6 | Negative | Online Inquiry |
KO38031 | EPB41L2 Knockout cell line (A549) | Human | EPB41L2 | 1:3~1:4 | Negative | Online Inquiry |
EPB41L2 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the expression of the EPB41L2 gene, which encodes for an essential protein involved in cytoskeletal organization and cell membrane integrity. This innovative product serves as a powerful tool for studying the functional roles of the EPB41L2 protein in various biological processes, including cellular signaling, adhesion, and movement.
The key function of these knockout cell lines is to provide an experimental model to elucidate the molecular pathways influenced by the EPB41L2 gene. By eliminating this gene, researchers can investigate compensatory mechanisms, interaction networks, and downstream effects that may arise due to its absence. Mechanistically, the lack of EPB41L2 can alter cytoskeletal dynamics, thereby affecting cellular morphology and motility, which can be pivotal in cancer research and developmental biology.
Scientific importance extends to both research and clinical settings, as EPB41L2 has been implicated in various pathological conditions. These knockout lines can help identify potential biomarkers or therapeutic targets in diseases where EPB41L2 dysregulation is implicated. Moreover, they facilitate high-throughput screening for drug candidates that can modulate pathways downstream of EPB41L2.
Compared to alternative models, such as shRNA-mediated knockdown or overexpressing wild-type EPB41L2, these knockout cell lines provide a more robust approach to study the complete absence of gene function without the residual protein levels that may confound results. This ensures that findings can be more confidently attributed to the loss of EPB41L2.
The value of EPB41L2 Gene Knockout Cell Lines to researchers, clinicians, and drug developers lies in their ability to deliver unambiguous insights into gene function and disease mechanisms. By utilizing these advanced tools, users can accelerate their research outcomes and enhance translational potential.
As experts in genetic engineering and provider of high-quality biological products, our company is committed to supporting the scientific community with innovative solutions that drive discovery and improve understanding in complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.